Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy
Abstract For residual N1 nodal disease following neoadjuvant chemotherapy (NAC) for patients with breast cancer, the optimal local therapy for axilla is an evolving area. We analyzed the long-term results of these patients according to axillary surgical methods using propensity score matching (PSM)...
Guardado en:
Autores principales: | Jung Whan Chun, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Sei-Hyun Ahn, Sae Byul Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2feac9d813874b62915da41dbe72c632 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
por: Sae Byul Lee, et al.
Publicado: (2021) -
Usefulness of 3D-surgical guides in breast conserving surgery after neoadjuvant treatment
por: Han Shin Lee, et al.
Publicado: (2021) -
Publisher Correction: Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients
por: Sungchan Gwark, et al.
Publicado: (2021) -
Contemporary use of sentinel lymph node biopsy in the head and neck
por: Nolan B. Seim, et al.
Publicado: (2016) -
Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights
por: Mor JM, et al.
Publicado: (2019)